FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity

Background: U19/EAF2 is a potential tumor suppressor exhibiting frequent down-regulation and allelic loss in advanced human prostate cancer specimens. U 19/EAF2 has also been identified as ELL-associated factor 2 (EAF2) based on its binding to ELL, a fusion partner of MLL in acute myeloid leukemia. U19/EAF2 is a putative transcription factor with a transactivation domain and capability of sequence-specific DNA binding. Methods: Yeast-two-hybrid-screening was used to identify U19/EAF2-binding partners. Co-immunoprecipitation and mammalian 1-hybrid assay were used to characterize a U19/EAF2-binding partner. Results: FB1, an E2A fusion partner in childhood leukemia, was identified as a binding-partner of U19/EAF2. FB1 also binds to EAF1, the only homologue of U19/EAF2. FB1 also interacts and co-localizes with ELL in the nucleus. Interestingly, FB1 inhibited the transcriptional activity of U19/EAF2 but not EAF1. Conclusions: FB1 is an important binding partner and a functional regulator of U19/EAF2, EAF1, and/or ELL. (c) 2007 Elsevier Ireland Ltd. All rights reserved.

四甲基乙撑桥联二环戊二烯基环戊二烯基稀土配合物的合成与表征

合成了四个甲基乙撑桥联二环戊二烯基环戊二烯基稀土四氢呋喃配合物,采用元素分析、红外光谱、核磁共板、热失重和质谱等方法对所得到配合物进行表征,并用X光衍射法测得Me_4C_2(C_5H_4)_2SmC_5H_3(THF)的晶体结构。该晶体属正交晶系C_(e2a)空间群,a=1.1696(6),b=1.2539(5),c=2.9432(15)nm;V=4.316(4)nm~3,z=8,D_c=1.54g·cm~(-3)。三个环戊二烯基Sm-C(η~5)距离分别为0.272(3),0.276(3),0.278(3)nm和Sm-O键长为0.253(1)nm。